4/A//SEC Filing
Rouan Sarah Kathryn 4/A
Accession 0000950170-25-052255
CIK 0001607678other
Filed
Apr 7, 8:00 PM ET
Accepted
Apr 8, 7:05 PM ET
Size
5.3 KB
Accession
0000950170-25-052255
Insider Transaction Report
Form 4/AAmended
Rouan Sarah Kathryn
Director
Transactions
- Purchase
Common Stock, par value $0.00001 per share
2025-03-31$24.15/sh+1,240$29,943→ 1,240 total
Footnotes (1)
- [F1]The Reporting Person's purchase of shares of the Issuer's common stock reported herein was matchable under Section 16(b) of the Securities Exchange Act of 1934, as amended, to the extent of 1,240 shares, with the Reporting Person's sale of shares of the Issuer's common stock at a price of $80.89 per share on October 25, 2024. The Reporting Person has, on a voluntary basis, made arrangements with the Issuer to pay $70,316.25 to the Issuer, representing the full amount of the profit realized in connection with the short-swing transaction, less transactions costs.
Documents
Issuer
Viking Therapeutics, Inc.
CIK 0001607678
Entity typeother
Related Parties
1- filerCIK 0001761366
Filing Metadata
- Form type
- 4/A
- Filed
- Apr 7, 8:00 PM ET
- Accepted
- Apr 8, 7:05 PM ET
- Size
- 5.3 KB